Cellectis SA (CLLS)

4.07 -0.02 (-0.37%) USD  |  NASDAQ  |  Jan 16, 16:00
3.90 -0.17 (-4.18%) After-Hours: 20:00
More

Cellectis Current Deferred Revenue (Per Share)

Current Deferred Revenue (Per Share) Chart

View Current Deferred Revenue (Per Share) for CLLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Per Share) Range, Past 5 Years

View Current Deferred Revenue (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Per Share) Benchmarks

View Current Deferred Revenue (Per Share) Benchmarks
Start Trial
EDAP TMS SA Upgrade
DBV Technologies SA --
Genfit SA Upgrade
Ascendis Pharma A/S --
Akari Therapeutics Plc --